Rid­ing Covid-19 high, As­pen plans new ad­di­tions at South African pro­duc­tion site

Changes are com­ing to As­pen Phar­ma­care’s plant in Gqe­ber­ha, South Africa.

The com­pa­ny will open the largest anes­thet­ics man­u­fac­tur­ing line in the south­ern hemi­sphere at the same site that it fills and pack­ages the J&J Covid-19 vac­cine, the com­pa­ny’s CEO Stephen Saad told re­porters Mon­day.

The ex­pan­sion could gen­er­ate an­oth­er $542 mil­lion in rev­enue a year. In 2018, As­pen start­ed man­u­fac­tur­ing drugs for late-stage can­cer, au­toim­mune ill­ness­es and Parkin­son’s dis­ease. Just last year, it start­ed fill-fin­ish op­er­a­tions for the J&J jab.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER